Lupin Ltd - Share Price
LUPIN
Lupin LtdFinancials
Lupin LtdNews & Updates
Nifty Pharma under selling pressure; Alkem, Torrent Pharma, Lupin weigh down
Jun 18,2021 11:15 AM
Heavyweight Divis Lab was the top gainer by 0.23% at Rs4,312.20.
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 668.50 | 71.95 | 160,371.55 | 327.39 | 1.12 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,197.30 | 56.94 | 111,305.67 | 487.93 | 0.48 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,283.90 | 40.21 | 87,906.42 | 311.50 | 0.47 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 960.90 | 31.37 | 77,443.53 | 413.41 | 0.52 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 620.40 | 38.96 | 63,492.52 | 464.70 | 0.56 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Lupin LtdSummary & Reports
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.Lupin Ltd was incorporated in th... More
Registered Office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai, Maharashtra,400055
Tell. : +91-22-6640 2323
Website : http://www.lupin.com
Email : info@lupin.com
Registrar Office
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in
Reports by lupin-ltd-share-price
Latest Release by lupin-ltd-share-price
Result Express
Lupin Ltd's Q3FY19 consolidated net profit declines 14.1% yoy to Rs190.47cr : Misses Estimates
Jun 19, 2021 12:16 PM
The company’s consolidated revenue stood at Rs4,504.87cr, up 13.31% yoy and 15.78% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.28% |
| Indian | 46.58% |
| Total Promoter | 46.86% |
| Non Promoter | - |
| Institutions | 40.45% |
| Non-Institutions | 12.69% |
| Total Non-Promoter | 53.14% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
12 May 2021
Annc. Date
03 May 2021
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
Purpose
Board Meeting
Exp. Date
28 Jan 2021
Annc. Date
12 Jan 2021
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
Purpose
Board Meeting
Exp. Date
04 Nov 2020
Annc. Date
20 Oct 2020
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
